- Thermo Fisher will begin manufacturing Moderna’s COVID-19 vaccine at its plant in Greenville, N.C., beginning during the third quarter of 2021, the company announced June 1.
- The National Institutes of Health launched a clinical trial to study the effects of a fully vaccinated person receiving a different booster shot. The trial will include distributing one Moderna booster shot to 150 people 12-20 weeks after they’ve been fully vaccinated with either Johnson & Johnson, Moderna or Pfizer-BioNTech’s vaccine. A second cohort will also include unvaccinated people.
- Moderna recently applied for full FDA approval of its COVID-19 vaccine for use in people ages 18 and older, the company announced June 1.
- The FDA and Johnson & Johnson are expected to announce soon that manufacturing problems at a Baltimore Emergent BioSolutions plant have been resolved. About 15 million Johnson & Johnson COVID-19 vaccine doses were ruined in March after employees mixed up ingredients with AstraZeneca’s COVID-19 vaccines.
- The CDC asked clinicians to report all cases of heart inflammation in patients who received COVID-19 vaccines to its Vaccine Adverse Event Reporting System.
- The U.S. Equal Employment Opportunity Commission recently stated that employers can legally require employees entering the workplace to receive a COVID-19 vaccine. In order to not violate EEOC laws, employers implementing a mandate must comply with reasonable accommodation provisions of the Americans with Disabilities Act, Title VII of the Civil Rights Act of 1964 and additional equal employment opportunity guidelines.
Moderna seeks full FDA approval; EEOC says employers can mandate vaccinations: Latest COVID-19 vaccine news
Here are six new developments about the COVID-19 vaccine from the last week:
Shared risk, shared data: What leaders say is really driving payer-provider alignment
Recommended Whitepaper